Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,555
Total Claims
$1.3M
Drug Cost
908
Beneficiaries
$1,448
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+8%
Opioid rate vs peers
49.6% vs 45.9% avg
+200%
Cost per patient vs peers
$1,448 vs $483 avg
+75%
Brand preference vs peers
7.2% vs 4.1% avg
Opioid Prescribing
49.6%
Opioid Rate
9,205
Opioid Claims
$907K
Opioid Cost
28.1%
Long-Acting Rate
This provider's opioid prescribing rate of 49.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,342 claims · $834K
Generic: 17,213 claims · $481K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 545 | $395K |
| Oxycodone Hcl | 318 | $158K |
| Oxycodone Hcl/Acetaminophen | 4,037 | $131K |
| Methylnaltrexone Bromide | 48 | $128K |
| Buprenorphine Hcl | 78 | $55K |
| Diclofenac Sodium | 295 | $34K |
| Hydrocodone/Acetaminophen | 1,027 | $31K |
| Naloxone Hcl | 344 | $30K |
| Gabapentin | 1,690 | $27K |
| Erenumab-Aooe | 35 | $27K |
| Fentanyl | 195 | $27K |
| Tizanidine Hcl | 2,329 | $26K |
| Pregabalin | 517 | $26K |
| Lidocaine | 71 | $20K |
| Celecoxib | 520 | $19K |
Prescribing Profile
44
Unique Drugs
15.0
Anomaly Score
Patient Profile
61
Avg Age
61%
Female
1.84
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data